au.\*:("CHER, Michael L")
Results 1 to 25 of 45
Selection :
Prostate Cancer: Basic and Translational ResearchCHER, Michael L.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, issn 0167-7659, 218 p.Serial Issue
Clinical and Translational Research in Prostate Cancer, Part ICHER, Michael L.Cancer metastasis reviews. 2002, Vol 21, Num 1, issn 0167-7659, 107 p.Serial Issue
The urokinase-type plasminogen activator system in prostate cancer metastasisSHIJIE SHENG.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, pp 287-296, issn 0167-7659Article
Prostate cancer diagnosis, staging and survivalNARAIN, Vivek; CHER, Michael L; WOOD, David P et al.Cancer metastasis reviews. 2002, Vol 21, Num 1, pp 17-27, issn 0167-7659, 11 p.Article
The future of cancer imagingBENARON, David A.Cancer metastasis reviews. 2002, Vol 21, Num 1, pp 45-78, issn 0167-7659, 34 p.Article
Chromosomal deletions and tumor suppressor genes in prostate cancerDONG, Jin-Tang.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, pp 173-193, issn 0167-7659Article
Signal transduction targets in androgen-independent prostate cancerJIAN ZHOU; SCHOLES, Jessica; HSIEH, Jer-Tsong et al.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, pp 351-362, issn 0167-7659Article
On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasisGORELIK, Elieser; GALILI, Uri; RAZ, Avraham et al.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, pp 245-277, issn 0167-7659Article
Angiogenesis in prostate cancer: Biology and therapeutic opportunitiesNICHOLSON, Brian; SCHAEFER, Greg; THEODORESCU, Dan et al.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, pp 297-319, issn 0167-7659Article
Integrins and prostate cancer metastasesFORNARO, Mara; MANES, Thomas; LANGUINO, Lucia R et al.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, pp 321-331, issn 0167-7659Article
Prostate cancer susceptibility genes: Many studies, many results, no answersNUPPONEN, Nina N; CARPTEN, John D.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, pp 155-164, issn 0167-7659Article
Primary full―gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD RegistryDHAR, Nivedita; WARD, John F; CHER, Michael L et al.BJU international (Papier). 2011, Vol 108, Num 4, pp 508-512, issn 1464-4096, 5 p.Article
Heterogeneous activation of MMP-9 due to prostate cancer-bone interactionWIESNER, Christoph; BONFIL, R. Daniel; ZHONG DONG et al.Urology (Ridgewood, NJ). 2007, Vol 69, Num 4, pp 795-799, issn 0090-4295, 5 p.Article
Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen cctivator/urokinase-type plasminogen activator receptor systemSHUPING YIN; LOCKETT, Jaron; CHER, Michael L et al.Cancer research (Baltimore). 2006, Vol 66, Num 8, pp 4173-4181, issn 0008-5472, 9 p.Article
Contribution of the androgen receptor to prostate cancer predisposition and progressionBUCHANAN, Grant; IRVINE, Ryan A; COETZEE, Gerhard A et al.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, pp 207-223, issn 0167-7659Article
Lycopene and soy isoflavones in the treatment of prostate cancerVAISHAMPAYAN, Ulka; HUSSAIN, Maha; KUCUK, Omer et al.Nutrition and cancer. 2007, Vol 59, Num 1, pp 1-7, issn 0163-5581, 7 p.Article
Prostate cancer-associated membrane type 1-matrix metalloproteinase a pivotal role in bone response and intraosseous tumor growthBONFIL, R. Daniel; ZHONG DONG; VESSELLA, Robert L et al.The American journal of pathology. 2007, Vol 170, Num 6, pp 2100-2111, issn 0002-9440, 12 p.Article
Molecular profiling in prostate cancerFEROZE-MERZOUG, F; SCHOBER, M. S; CHEN, Y. Q et al.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, pp 165-171, issn 0167-7659Article
Role of eicosanoids in prostate cancer progressionDAOTAI NIE; MINGXIN CHE; GRIGNON, David et al.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, pp 195-206, issn 0167-7659Article
Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand/MMP-9 signaling in prostate cancerYIWEI LI; KUCUK, Omer; HUSSAIN, Maha et al.Cancer research (Baltimore). 2006, Vol 66, Num 9, pp 4816-4825, issn 0008-5472, 10 p.Article
The diet, prostate inflammation, and the development of prostate cancerNELSON, William G; DEWEESE, Theodore L; DEMARZO, Angelo M et al.Cancer metastasis reviews. 2002, Vol 21, Num 1, pp 3-16, issn 0167-7659, 14 p.Article
Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis : Biologic, translational, and clinical advanes in urologic oncologyBONFIL, R. Daniel; CHINNI, Sreenivasa; FRIDMAN, Rafael et al.Urologic oncology. 2007, Vol 25, Num 5, pp 407-411, issn 1078-1439, 5 p.Conference Paper
Antisense therapy: Current status in prostate cancer and other malignanciesGLEAVE, Martin; MIYAKE, Hideake; ZANGEMEISTER-WITTKE, Uwe et al.Cancer metastasis reviews. 2002, Vol 21, Num 1, pp 79-92, issn 0167-7659, 14 p.Article
Regulation of apoptosis in prostate cancerGURUMURTHY, Sushma; KRISHNA MURTHI VASUDEVAN; RANGNEKAR, Vivek M et al.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, pp 225-243, issn 0167-7659Article
Metastasis suppression in prostate cancerJAEGER, Erich R; SAMANT, Raieey S; RINKER-SCHAEFFER, Carrie W et al.Cancer metastasis reviews. 2001, Vol 20, Num 3-4, pp 279-286, issn 0167-7659Article